Stock 2289 CHARMACY PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Charmacy Pharmaceutical Co., Ltd. Share Price

Equities

2289

CNE1000023D6

Drug Retailers

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
13.94 HKD -0.29% Intraday chart for Charmacy Pharmaceutical Co., Ltd. +39.68% +7.56%
04-01 Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains MT
03-28 Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024 CI

Financials

Sales 2021 3.79B 524M 4.1B 41.93B Sales 2022 4.18B 576M 4.51B 46.14B Capitalization 657M 90.7M 710M 7.26B
Net income 2021 23M 3.17M 24.85M 254M Net income 2022 90M 12.42M 97.23M 995M EV / Sales 2021 0.31 x
Net Debt 2021 685M 94.59M 740M 7.58B Net Debt 2022 682M 94.08M 737M 7.53B EV / Sales 2022 0.32 x
P/E ratio 2021
21.2 x
P/E ratio 2022
7.27 x
Employees 831
Yield 2021 *
-
Yield 2022
7.4%
Free-Float 24%
More Fundamentals * Assessed data

Chart Charmacy Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news about Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains MT
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023 MT
Charmacy Pharmaceutical Meets Minimum Public Float Norms MT
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023 CI
Charmacy Pharmaceutical Chairman Steps Down MT
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes CI
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023 CI
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6% MT
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives CI
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder MT
More news

Press releases Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical : EXCHANGE NOTICE - TRADING HALT PU
Charmacy Pharmaceutical : FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD AT THE CONFERENCE ROOM ON 3RD FLOOR, NO. 235 SONG SHAN NORTH ROAD, LONGHU DISTRICT, SHANTOU CITY, GUANGDONG PROVINCE, THE PRC ON 31 MAY 2021 at 10 A.M. OR AT ANY ADJOURNMENT THEREOF PU
Charmacy Pharmaceutical : (1) PROPOSED ELECTION OF DIRECTORS OF THE THIRD SESSION OF THE BOARD; AND (2) PROPOSED ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISOR AND INDEPENDENT SUPERVISOR OF THE THIRD SESSION OF THE SUPERVISORY COMMITTEE PU
Charmacy Pharmaceutical : CHANGE OF BUILDING NAME OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG PU
FORM OF PROXY FOR USE AT THE 2020 FIRST H SHAREHOLDERS' CLASS MEETING TO BE HELD AT THE CONFERENCE ROOM ON 3RD FLOOR, NO. 235 SONG SHAN NORTH ROAD, LONGHU DISTRICT, SHANTOU CITY, GUANGDONG PROVINCE, THE PRC, ON 20 JANUARY 2020 AT 11:00A.M. OR ANY ADJOURNMENT THEREOF PU
More press releases

Quotes and Performance

1 day-0.29%
1 week+39.68%
Current month+34.04%
1 month+39.40%
3 months+34.56%
6 months+0.87%
Current year+7.56%
More quotes

Highs and lows

1 week
9.80
Extreme 9.8
14.82
1 month
9.71
Extreme 9.71
14.82
Current year
8.86
Extreme 8.86
14.82
1 year
5.90
Extreme 5.9
20.00
3 years
4.46
Extreme 4.46
20.00
5 years
4.01
Extreme 4.01
20.00
10 years
4.01
Extreme 4.01
20.00
More quotes

Managers and Directors - Charmacy Pharmaceutical Co., Ltd.

Managers TitleAgeSince
Chuang Long Yao CEO
 Chief Executive Officer 54 05/03/00
Han Zi Zhang DFI
 Director of Finance/CFO 45 12/07/22
Zhi Jie Lin BRD
 Director/Board Member 40 -
Members of the board TitleAgeSince
Chuang Long Yao CEO
 Chief Executive Officer 54 05/03/00
Yu Yan Zheng BRD
 Director/Board Member 49 -
Chi Wai Wan BRD
 Director/Board Member 48 30/11/15
More insiders

Quotes

Date Price Change Volume
26/04/24 13.94 -0.29% 133,000
25/04/24 13.98 -5.67% 462,000
24/04/24 14.82 +50.15% 91,500
23/04/24 9.87 0.00% 7,000
22/04/24 9.87 -1.10% 185,500

Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am

More quotes

Company Profile

Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the People’s Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.
Sector
Drug Retailers
Calendar
25/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
CHARMACY PHARMACEUTICAL CO., LTD. Stock Charmacy Pharmaceutical Co., Ltd.
+7.56% 192M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 2289 Stock